• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞中的外泌体,一种治疗心血管疾病的新策略?

Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?

作者信息

Huang Lina, Ma Wenya, Ma Yidi, Feng Dan, Chen Hongyang, Cai Benzhi

机构信息

Department of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin 150081, China.

出版信息

Int J Biol Sci. 2015 Jan 12;11(2):238-45. doi: 10.7150/ijbs.10725. eCollection 2015.

DOI:10.7150/ijbs.10725
PMID:25632267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4308409/
Abstract

Cardiovascular diseases (CVDs) are still a major cause of people deaths worldwide, and mesenchymal stem cells (MSCs) transplantation holds great promise due to its capacity to differentiate into cardiovascular cells and secrete protective cytokines, which presents an important mechanism of MSCs therapy for CVDs. Although the capability of MSCs to differentiate into cardiomyocytes (CMCs), endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) has been well recognized in massive previous experiments both in vitro and in vivo, low survival rate of transplanted MSCs in recipient hearts suggests that therapeutic effects of MSCs transplantation might be also correlated with other underlying mechanisms. Notably, recent studies uncovered that MSCs were able to secret cholesterol-rich, phospholipid exosomes which were enriched with microRNAs (miRNAs). The released exosomes from MSCs acted on hearts and vessels, and then exerted anti-apoptosis, cardiac regeneration, anti-cardiac remodeling, anti-inflammatory effects, neovascularization and anti-vascular remodeling, which are considered as novel molecular mechanisms of therapeutic potential of MSCs transplantation. Here we summarized recent advances about the role of exosomes in MSCs therapy for CVDs, and discussed exosomes as a novel approach in the treatment of CVDs in the future.

摘要

心血管疾病(CVDs)仍是全球人口死亡的主要原因,而间充质干细胞(MSCs)移植因其能够分化为心血管细胞并分泌保护性细胞因子而具有巨大潜力,这是MSCs治疗CVDs的重要机制。尽管在大量先前的体内和体外实验中,MSCs分化为心肌细胞(CMCs)、内皮细胞(ECs)和血管平滑肌细胞(VSMCs)的能力已得到充分认可,但移植的MSCs在受体心脏中的低存活率表明,MSCs移植的治疗效果可能还与其他潜在机制有关。值得注意的是,最近的研究发现,MSCs能够分泌富含胆固醇的磷脂外泌体,这些外泌体富含微小RNA(miRNAs)。MSCs释放的外泌体作用于心脏和血管,进而发挥抗凋亡、心脏再生、抗心脏重塑、抗炎、新血管形成和抗血管重塑作用,这些被认为是MSCs移植治疗潜力的新分子机制。在此,我们总结了外泌体在MSCs治疗CVDs中的作用的最新进展,并讨论了外泌体作为未来治疗CVDs的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/7293bbc5d305/ijbsv11p0238g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/82c524331ae4/ijbsv11p0238g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/d7625366c215/ijbsv11p0238g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/7293bbc5d305/ijbsv11p0238g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/82c524331ae4/ijbsv11p0238g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/d7625366c215/ijbsv11p0238g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a1b/4308409/7293bbc5d305/ijbsv11p0238g003.jpg

相似文献

1
Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?间充质干细胞中的外泌体,一种治疗心血管疾病的新策略?
Int J Biol Sci. 2015 Jan 12;11(2):238-45. doi: 10.7150/ijbs.10725. eCollection 2015.
2
Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration.间充质干细胞衍生的外泌体:心脏再生的一种新型潜在治疗途径。
Cell Mol Biol (Noisy-le-grand). 2016 Jun 30;62(7):66-73.
3
Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease.间充质干细胞来源的外泌体在心血管疾病中的治疗作用
Adv Exp Med Biol. 2017;998:179-185. doi: 10.1007/978-981-10-4397-0_12.
4
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.间质干细胞外泌体:一种基于干细胞的新型心血管疾病治疗方法。
Regen Med. 2011 Jul;6(4):481-92. doi: 10.2217/rme.11.35.
5
[PROGRESS OF MESENCHYMAL STEM CELL-DERIVED Exosomes IN TISSUE REPAIR].[间充质干细胞来源的外泌体在组织修复中的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Feb;29(2):234-8.
6
Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.干细胞衍生外泌体作为心血管治疗的重要工具的新兴作用。
Curr Stem Cell Res Ther. 2017;12(2):134-138. doi: 10.2174/1574888X10666151026115320.
7
Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis.间充质干细胞衍生的外泌体:一种治疗骨质疏松症的可能策略。
Curr Stem Cell Res Ther. 2018;13(5):362-368. doi: 10.2174/1574888X13666180403163456.
8
Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species.人骨髓间充质干细胞和脂肪间充质干细胞分泌富含独特微小RNA(miRNA)和转运RNA(tRNA)种类的外泌体。
Stem Cell Res Ther. 2015 Jul 1;6(1):127. doi: 10.1186/s13287-015-0116-z.
9
Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.间充质干细胞衍生的外泌体可加速骨骼肌再生。
FEBS Lett. 2015 May 8;589(11):1257-65. doi: 10.1016/j.febslet.2015.03.031. Epub 2015 Apr 8.
10
Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis.外泌体miR-223有助于间充质干细胞在多微生物脓毒症中引发心脏保护作用。
Sci Rep. 2015 Sep 8;5:13721. doi: 10.1038/srep13721.

引用本文的文献

1
Tissue engineering strategies for treating intervertebral disc degeneration.治疗椎间盘退变的组织工程策略
Front Bioeng Biotechnol. 2025 Jul 14;13:1582189. doi: 10.3389/fbioe.2025.1582189. eCollection 2025.
2
Engineering small extracellular vesicles: Unlocking the brain's secret passage for central nervous system therapies.工程化小细胞外囊泡:开启用于中枢神经系统治疗的大脑秘密通道。
J Cereb Blood Flow Metab. 2025 Jun 19:271678X251348816. doi: 10.1177/0271678X251348816.
3
Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy.

本文引用的文献

1
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.内皮细胞中miR-126的外泌体转运调节慢性粒细胞白血病细胞的黏附与迁移能力。
Mol Cancer. 2014 Jul 11;13:169. doi: 10.1186/1476-4598-13-169.
2
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.来自骨髓间充质干细胞的外泌体含有一种促进转移性乳腺癌细胞休眠的微小核糖核酸。
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.
3
Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential.
靶向斑块的血小板膜修饰外泌体激活血管平滑肌细胞自噬以治疗动脉粥样硬化
Drug Deliv Transl Res. 2025 Jan 28. doi: 10.1007/s13346-025-01792-1.
4
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.基因修饰间充质基质细胞:一种细胞疗法,能在心肌梗死后提供更有效的修复。
Stem Cell Res Ther. 2024 Sep 27;15(1):323. doi: 10.1186/s13287-024-03942-7.
5
Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseases.利用间充质干细胞衍生外泌体在退行性疾病中的潜力。
Regen Ther. 2024 Aug 20;26:599-610. doi: 10.1016/j.reth.2024.08.001. eCollection 2024 Jun.
6
Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges.间充质干细胞作为心血管再生的未来治疗方法及其面临的挑战。
Ann Transl Med. 2024 Aug 1;12(4):73. doi: 10.21037/atm-23-1936. Epub 2023 Dec 29.
7
Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-κB signaling pathway after myocardial ischemia-reperfusion injury.通过 IMTP 修饰的牛奶外泌体靶向递送 miR-146a,通过抑制心肌缺血再灌注损伤后的 NF-κB 信号通路发挥心脏保护作用。
J Nanobiotechnology. 2024 Jul 1;22(1):382. doi: 10.1186/s12951-024-02631-0.
8
Role of mesenchymal stem cell-derived exosomes in the regeneration of different tissues.间充质干细胞衍生外泌体在不同组织再生中的作用。
J Biol Eng. 2024 Jun 6;18(1):36. doi: 10.1186/s13036-024-00431-6.
9
3D bioprinted aged human post-infarct myocardium tissue model.3D生物打印的老年人心肌梗死后组织模型
Health Sci Rep. 2024 Apr 22;7(4):e1945. doi: 10.1002/hsr2.1945. eCollection 2024 Apr.
10
Application of exosomes in tumor immunity: recent progresses.外泌体在肿瘤免疫中的应用:最新进展
Front Cell Dev Biol. 2024 Apr 3;12:1372847. doi: 10.3389/fcell.2024.1372847. eCollection 2024.
血小板衍生生长因子调节脂肪间充质干细胞分泌细胞外囊泡,并增强其血管生成潜能。
Cell Commun Signal. 2014 Apr 11;12:26. doi: 10.1186/1478-811X-12-26.
4
Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.外泌体介导的慢性髓性白血病细胞与人骨髓基质细胞之间的串扰触发了白细胞介素 8 依赖性白血病细胞存活。
Cancer Lett. 2014 Jun 28;348(1-2):71-6. doi: 10.1016/j.canlet.2014.03.009. Epub 2014 Mar 18.
5
Islet-1 overexpression in human mesenchymal stem cells promotes vascularization through monocyte chemoattractant protein-3.人骨髓间充质干细胞中Islet-1的过表达通过单核细胞趋化蛋白-3促进血管生成。
Stem Cells. 2014 Jul;32(7):1843-54. doi: 10.1002/stem.1682.
6
Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22.缺血预处理通过miR-22靶向Mecp2,经由外泌体分泌增强干细胞的保护作用。
PLoS One. 2014 Feb 18;9(2):e88685. doi: 10.1371/journal.pone.0088685. eCollection 2014.
7
Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.胃癌组织来源的间充质干细胞中失调的微小RNA:新型生物标志物及胃癌发生机制
Br J Cancer. 2014 Mar 4;110(5):1199-210. doi: 10.1038/bjc.2014.14. Epub 2014 Jan 28.
8
Exosomes and cardiac repair after myocardial infarction.细胞外囊泡与心肌梗死后的心脏修复。
Circ Res. 2014 Jan 17;114(2):333-44. doi: 10.1161/CIRCRESAHA.114.300639.
9
Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.间充质干细胞来源的外泌体通过下调乳腺癌细胞中 VEGF 的表达抑制血管生成。
PLoS One. 2013 Dec 31;8(12):e84256. doi: 10.1371/journal.pone.0084256. eCollection 2013.
10
Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing.使用下一代测序技术对人乳腺癌细胞系分泌的外泌体中的 RNA 进行表征。
PeerJ. 2013 Nov 5;1:e201. doi: 10.7717/peerj.201. eCollection 2013.